SRRK
Scholar Rock Holding Corp
NASDAQ: SRRK · HEALTHCARE · BIOTECHNOLOGY
$46.30
-0.92% today
Updated 2026-04-29
Market cap
$5.57B
P/E ratio
—
P/S ratio
13.14x
EPS (TTM)
$-3.29
Dividend yield
—
52W range
$27 – $52
Volume
1.6M
Scholar Rock Holding Corp (SRRK) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | $32.78M | $61.64M | $181.34M | $196.38M | $388.31M | $304.44M | $358.17M | $311.04M | $474.92M |
| Cash & equivalents | $10.03M | $56.46M | $115.07M | $36.31M | $160.36M | $212.84M | $103.28M | $101.86M | $177.88M |
| Current assets | $28.50M | $59.20M | $177.94M | $185.17M | $344.40M | $265.32M | $328.02M | $288.19M | $451.17M |
| Total liabilities | $62.81M | $115.16M | $74.71M | $83.48M | $127.53M | $132.37M | $97.93M | $85.82M | $106.29M |
| Current liabilities | $3.01M | $5.02M | $31.12M | $32.81M | $42.56M | $64.30M | $36.39M | $32.74M | $46.94M |
| Long-term debt | $1.02M | $398000.00 | $24000.00 | $9000.00 | $24.68M | $48.42M | $49.74M | $48.68M | $50.15M |
| Shareholder equity | $-30.03M | $-53.52M | $106.62M | $112.90M | $260.77M | $172.07M | $260.24M | $225.22M | $368.63M |
| Retained earnings | $-32.53M | $-57.52M | $-106.85M | $-157.85M | $-244.33M | $-376.13M | $-510.63M | $-676.42M | $-922.72M |
| Accounts receivable | $95000.00 | — | — | $25.00M | $0.00 | — | $2.73M | $1.08M | $2.15M |
| Inventory | — | — | — | $-25.00M | — | — | $-2.73M | — | — |
| Goodwill | — | — | — | — | — | — | — | — | — |